FGF23 and mesenchymal cell neoplasm: Tumor-induced osteomalacia (TIO), or oncogenic osteomalacia, results from excessive fibroblast growth factor 23 (FGF23) secretion by phosphaturic mesenchymal tumors (PMTs), leading to renal phosphate wasting and hypovitaminosis D [78,79,80].